David Belada

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 5

Top Topics

Chronic Lymphocytic Leukemia

Prognostic Factors

Ejection Fraction

Cross Sectional

Top Venues

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Pavel Vodárek, Dominika Écsiová, Vladimíra Řezáčová, Ondřej Souček, Martin Simkovic, Doris Vokurková, David Belada, Pavel Žák, Vítězslav Bryja
Complex evaluation of serum immunoglobulin levels in patients with chronic lymphocytic leukemia: Significant increase in IgA after first-line chemoimmunotherapy. Cancer medicine 13 (15) (2024)
Pavel Vodárek, Dominika Écsiová, Vladimíra Řezáčová, Ondřej Souček, Martin Simkovic, Doris Vokurková, David Belada, Pavel Žák, Vítězslav Bryja
Complex evaluation of serum immunoglobulin levels in patients with chronic lymphocytic leukemia: Significant increase in IgA after first-line chemoimmunotherapy. Cancer medicine 13 (15) (2024)
Pavel Vodárek, Dominika Écsiová, Vladimíra Řezáčová, Ondřej Souček, Martin Simkovic, Doris Vokurková, David Belada, Pavel Žák, Vítězslav Bryja
Complex evaluation of serum immunoglobulin levels in patients with chronic lymphocytic leukemia: Significant increase in IgA after first-line chemoimmunotherapy. Cancer medicine 13 (15) (2024)
Pavel Vodárek, Dominika Écsiová, Vladimíra Řezáčová, Ondřej Souček, Martin Simkovic, Doris Vokurková, David Belada, Pavel Žák, Vítězslav Bryja
A comprehensive assessment of lymphocyte subsets, their prognostic significance, and changes after first-line therapy administration in patients with chronic lymphocytic leukemia. Cancer medicine (2022)
Vít Procházka, David Belada, Andrea Janikova, Kateřina Benešová, Heidi Mocikova, Juraj Ďuraš, Jan Pirnos, Kateřina Kopečková, Vít Campr, Tomáš Fürst, Robert Pytlik, Alice Sýkorová, Jozef Michalka, Jitka Dlouhá, Tomáš Papajík, Marek Trněný
Rituximab maintenance significantly reduces early follicular lymphoma progressions in patients treated with frontline R-CHOP. EJHaem 1 (1) (2020)